Fate Therapeutics Stock Price on July 1, 2024

FATE Stock  USD 1.66  0.02  1.19%   
Below is the normalized historical share price chart for Fate Therapeutics extending back to October 01, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fate Therapeutics stands at 1.66, as last reported on the 25th of December, with the highest price reaching 1.69 and the lowest price hitting 1.57 during the day.
IPO Date
1st of October 2013
200 Day MA
3.8988
50 Day MA
2.5008
Beta
1.879
 
Yuan Drop
 
Covid
If you're considering investing in Fate Stock, it is important to understand the factors that can impact its price. Fate Therapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which denotes the company had a -0.14% return per unit of risk over the last 3 months. Fate Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fate Therapeutics' Mean Deviation of 5.08, standard deviation of 6.56, and Variance of 43.06 to check the risk estimate we provide.
  
At present, Fate Therapeutics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to about 522.2 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 54.2 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.06, whereas Price To Sales Ratio is forecasted to decline to 5.50. Fate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1443

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsFATE

Estimated Market Risk

 6.66
  actual daily
59
59% of assets are less volatile

Expected Return

 -0.96
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.14
  actual daily
0
Most of other assets perform better
Based on monthly moving average Fate Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fate Therapeutics by adding Fate Therapeutics to a well-diversified portfolio.
Price Book
0.5218
Enterprise Value Ebitda
(2.59)
Price Sales
14.0599
Shares Float
98.8 M
Wall Street Target Price
6.3077

Related Headline

Intellia Therapeutics Headline on 1st of July 2024

Filed transaction by Intellia Therapeutics Officer: Vp, Pao And Interim Pfo. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Fate Therapeutics Valuation on July 1, 2024

It is possible to determine the worth of Fate Therapeutics on a given historical date. On July 1, 2024 Fate was worth 3.3 at the beginning of the trading date compared to the closed value of 3.26. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fate Therapeutics stock. Still, in general, we apply an absolute valuation method to find Fate Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fate Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fate Therapeutics' related companies.
 Open High Low Close Volume
  3.25    3.30    3.13    3.28    3,809,549  
07/01/2024
  3.30    3.39    3.21    3.26    1,035,215  
  3.23    3.25    3.09    3.22    1,227,377  
Backtest Fate Therapeutics  |  Fate Therapeutics History  |  Fate Therapeutics Valuation   PreviousNext  
Open Value
3.3
3.26
Closing Value
23.28
Upside

Fate Therapeutics Trading Date Momentum on July 1, 2024

On July 02 2024 Fate Therapeutics was traded for  3.22  at the closing time. The top price for the day was 3.25  and the lowest listed price was  3.09 . The trading volume for the day was 1.2 M. The trading history from July 2, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.23% . The overall trading delta against the current closing price is 1.23% .

Fate Therapeutics Fundamentals Correlations and Trends

By evaluating Fate Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fate Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fate financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Fate Therapeutics Stock history

Fate Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fate Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fate Therapeutics stock prices may prove useful in developing a viable investing in Fate Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding98.4 M54.2 M
Net Loss-253.5 M-240.9 M

Fate Therapeutics Quarterly Net Working Capital

272.87 Million

Fate Therapeutics Stock Technical Analysis

Fate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Fate Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Fate Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Fate Therapeutics Period Price Range

Low
December 25, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Fate Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Fate Therapeutics December 25, 2024 Market Strength

Market strength indicators help investors to evaluate how Fate Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fate Therapeutics shares will generate the highest return on investment. By undertsting and applying Fate Therapeutics stock market strength indicators, traders can identify Fate Therapeutics entry and exit signals to maximize returns

Fate Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Fate Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Fate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Fate Stock analysis

When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities